APO Research
Talk to an analyst

APO RESEARCH · REPORT

Coartem (Artemether & Lumefantrine)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Coartem (Artemether & Lumefantrine) Market Outlook and Growth Opportunities 2026

21 December 2025192 pages

Choose your research edition.

Industry ResearchCoartem (Artemether & Lumefantrine) Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Coartem (Artemether & Lumefantrine) Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Coartem (Artemether & Lumefantrine) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coartem (Artemether & Lumefantrine) Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Coartem (Artemether & Lumefantrine) Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Coartem (Artemether & Lumefantrine) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Coartem (Artemether & Lumefantrine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Coartem (Artemether & Lumefantrine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Coartem (Artemether & Lumefantrine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Coartem (Artemether & Lumefantrine) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Coartem (Artemether & Lumefantrine) market include Novartis, Kunming Pharmaceutical, Kerui Nanhai Pharmaceutical, Guilin Pharmaceutical Co., Ltd, Guangxi Xiancaotang Pharmaceutical Co., LTD, Sanofi-Aventis and KPC Pharmaceuticals, Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Coartem (Artemether & Lumefantrine) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Coartem (Artemether & Lumefantrine) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Coartem (Artemether & Lumefantrine) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Coartem (Artemether & Lumefantrine) market size, projected growth trends, production technologies, key applications, and end-use industries.

Coartem (Artemether & Lumefantrine) Segment by Company

Novartis

Kunming Pharmaceutical

Kerui Nanhai Pharmaceutical

Guilin Pharmaceutical Co., Ltd

Guangxi Xiancaotang Pharmaceutical Co., LTD

Sanofi-Aventis

KPC Pharmaceuticals, Inc

Coartem (Artemether & Lumefantrine) Segment by Type

Artemether

Lumefantrine

Coartem (Artemether & Lumefantrine) Segment by Application

Retail Pharmacy

Online Pharmacy

Hospital Pharmacy

Coartem (Artemether & Lumefantrine) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Coartem (Artemether & Lumefantrine) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Coartem (Artemether & Lumefantrine) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Coartem (Artemether & Lumefantrine) significant trends, drivers, influence factors in global and regions.

6. To analyze Coartem (Artemether & Lumefantrine) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coartem (Artemether & Lumefantrine) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coartem (Artemether & Lumefantrine) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coartem (Artemether & Lumefantrine).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Coartem (Artemether & Lumefantrine) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Coartem (Artemether & Lumefantrine) industry.

Chapter 3: Detailed analysis of Coartem (Artemether & Lumefantrine) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Coartem (Artemether & Lumefantrine) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Coartem (Artemether & Lumefantrine) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Coartem (Artemether & Lumefantrine) Industry Trends Table 2. Coartem (Artemether & Lumefantrine) Industry Drivers Table 3. Coartem (Artemether & Lumefantrine) Industry Opportunities and Challenges Table 4. Coartem (Artemether & Lumefantrine) Industry Restraints Table 5. Global Coartem (Artemether & Lumefantrine) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Coartem (Artemether & Lumefantrine) Revenue Share by Company (2021-2026) Table 7. Global Coartem (Artemether & Lumefantrine) Sales Volume by Company (k units) & (2021-2026) Table 8. Global Coartem (Artemether & Lumefantrine) Sales Volume Share by Company (2021-2026) Table 9. Global Coartem (Artemether & Lumefantrine) Average Price (US$/unit) of Company (2021-2026) Table 10. Global Coartem (Artemether & Lumefantrine) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Coartem (Artemether & Lumefantrine) Key Company Manufacturing Base & Headquarters Table 12. Global Coartem (Artemether & Lumefantrine) Company, Product Type & Application Table 13. Global Coartem (Artemether & Lumefantrine) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Coartem (Artemether & Lumefantrine) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Artemether Table 18. Significant Companies of Lumefantrine Table 19. Global Coartem (Artemether & Lumefantrine) Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Coartem (Artemether & Lumefantrine) Sales Volume by Type (2021-2026) & (k units) Table 21. Global Coartem (Artemether & Lumefantrine) Sales Volume by Type (2027-2032) & (k units) Table 22. Global Coartem (Artemether & Lumefantrine) Sales Volume Share by Type (2021-2026) Table 23. Global Coartem (Artemether & Lumefantrine) Sales Volume Share by Type (2027-2032) Table 24. Global Coartem (Artemether & Lumefantrine) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Coartem (Artemether & Lumefantrine) Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Coartem (Artemether & Lumefantrine) Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Coartem (Artemether & Lumefantrine) Sales Value Share by Type (2021-2026) Table 28. Global Coartem (Artemether & Lumefantrine) Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Retail Pharmacy Table 30. Significant Companies of Online Pharmacy Table 31. Significant Companies of Hospital Pharmacy Table 32. Global Coartem (Artemether & Lumefantrine) Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Coartem (Artemether & Lumefantrine) Sales Volume by Application (2021-2026) & (k units) Table 34. Global Coartem (Artemether & Lumefantrine) Sales Volume by Application (2027-2032) & (k units) Table 35. Global Coartem (Artemether & Lumefantrine) Sales Volume Share by Application (2021-2026) Table 36. Global Coartem (Artemether & Lumefantrine) Sales Volume Share by Application (2027-2032) Table 37. Global Coartem (Artemether & Lumefantrine) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Coartem (Artemether & Lumefantrine) Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Coartem (Artemether & Lumefantrine) Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Coartem (Artemether & Lumefantrine) Sales Value Share by Application (2021-2026) Table 41. Global Coartem (Artemether & Lumefantrine) Sales Value Share by Application (2027-2032) Table 42. Global Coartem (Artemether & Lumefantrine) Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Coartem (Artemether & Lumefantrine) Sales by Region (2021-2026) & (k units) Table 44. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Region (2021-2026) Table 45. Global Coartem (Artemether & Lumefantrine) Sales by Region (2027-2032) & (k units) Table 46. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Region (2027-2032) Table 47. Global Coartem (Artemether & Lumefantrine) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Coartem (Artemether & Lumefantrine) Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Coartem (Artemether & Lumefantrine) Sales Value Share by Region (2021-2026) Table 50. Global Coartem (Artemether & Lumefantrine) Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Coartem (Artemether & Lumefantrine) Sales Value Share by Region (2027-2032) Table 52. Global Coartem (Artemether & Lumefantrine) Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Coartem (Artemether & Lumefantrine) Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Coartem (Artemether & Lumefantrine) Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Coartem (Artemether & Lumefantrine) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Coartem (Artemether & Lumefantrine) Sales by Country (2021-2026) & (k units) Table 57. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Country (2021-2026) Table 58. Global Coartem (Artemether & Lumefantrine) Sales by Country (2027-2032) & (k units) Table 59. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Country (2027-2032) Table 60. Global Coartem (Artemether & Lumefantrine) Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Coartem (Artemether & Lumefantrine) Sales Value Market Share by Country (2021-2026) Table 62. Global Coartem (Artemether & Lumefantrine) Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Coartem (Artemether & Lumefantrine) Sales Value Market Share by Country (2027-2032) Table 64. Novartis Company Information Table 65. Novartis Business Overview Table 66. Novartis Coartem (Artemether & Lumefantrine) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Novartis Coartem (Artemether & Lumefantrine) Product Portfolio Table 68. Novartis Recent Development Table 69. Kunming Pharmaceutical Company Information Table 70. Kunming Pharmaceutical Business Overview Table 71. Kunming Pharmaceutical Coartem (Artemether & Lumefantrine) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Kunming Pharmaceutical Coartem (Artemether & Lumefantrine) Product Portfolio Table 73. Kunming Pharmaceutical Recent Development Table 74. Kerui Nanhai Pharmaceutical Company Information Table 75. Kerui Nanhai Pharmaceutical Business Overview Table 76. Kerui Nanhai Pharmaceutical Coartem (Artemether & Lumefantrine) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Kerui Nanhai Pharmaceutical Coartem (Artemether & Lumefantrine) Product Portfolio Table 78. Kerui Nanhai Pharmaceutical Recent Development Table 79. Guilin Pharmaceutical Co., Ltd Company Information Table 80. Guilin Pharmaceutical Co., Ltd Business Overview Table 81. Guilin Pharmaceutical Co., Ltd Coartem (Artemether & Lumefantrine) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Guilin Pharmaceutical Co., Ltd Coartem (Artemether & Lumefantrine) Product Portfolio Table 83. Guilin Pharmaceutical Co., Ltd Recent Development Table 84. Guangxi Xiancaotang Pharmaceutical Co., LTD Company Information Table 85. Guangxi Xiancaotang Pharmaceutical Co., LTD Business Overview Table 86. Guangxi Xiancaotang Pharmaceutical Co., LTD Coartem (Artemether & Lumefantrine) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Guangxi Xiancaotang Pharmaceutical Co., LTD Coartem (Artemether & Lumefantrine) Product Portfolio Table 88. Guangxi Xiancaotang Pharmaceutical Co., LTD Recent Development Table 89. Sanofi-Aventis Company Information Table 90. Sanofi-Aventis Business Overview Table 91. Sanofi-Aventis Coartem (Artemether & Lumefantrine) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Sanofi-Aventis Coartem (Artemether & Lumefantrine) Product Portfolio Table 93. Sanofi-Aventis Recent Development Table 94. KPC Pharmaceuticals, Inc Company Information Table 95. KPC Pharmaceuticals, Inc Business Overview Table 96. KPC Pharmaceuticals, Inc Coartem (Artemether & Lumefantrine) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. KPC Pharmaceuticals, Inc Coartem (Artemether & Lumefantrine) Product Portfolio Table 98. KPC Pharmaceuticals, Inc Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Coartem (Artemether & Lumefantrine) Distributors List Table 102. Coartem (Artemether & Lumefantrine) Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Coartem (Artemether & Lumefantrine) Product Image Figure 2. Global Coartem (Artemether & Lumefantrine) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Coartem (Artemether & Lumefantrine) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Coartem (Artemether & Lumefantrine) Sales (2021-2032) & (k units) Figure 5. Global Coartem (Artemether & Lumefantrine) Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Coartem (Artemether & Lumefantrine) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Artemether Image Figure 10. Lumefantrine Image Figure 11. Global Coartem (Artemether & Lumefantrine) Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Coartem (Artemether & Lumefantrine) Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Coartem (Artemether & Lumefantrine) Sales Volume Share by Type (2021-2032) Figure 14. Global Coartem (Artemether & Lumefantrine) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Coartem (Artemether & Lumefantrine) Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Coartem (Artemether & Lumefantrine) Sales Value Share by Type (2021-2032) Figure 17. Retail Pharmacy Image Figure 18. Online Pharmacy Image Figure 19. Hospital Pharmacy Image Figure 20. Global Coartem (Artemether & Lumefantrine) Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Coartem (Artemether & Lumefantrine) Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Coartem (Artemether & Lumefantrine) Sales Volume Share by Application (2021-2032) Figure 23. Global Coartem (Artemether & Lumefantrine) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Coartem (Artemether & Lumefantrine) Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Coartem (Artemether & Lumefantrine) Sales Value Share by Application (2021-2032) Figure 26. Global Coartem (Artemether & Lumefantrine) Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Coartem (Artemether & Lumefantrine) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Coartem (Artemether & Lumefantrine) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Coartem (Artemether & Lumefantrine) Sales Value (2021-2032) & (US$ Million) Figure 31. North America Coartem (Artemether & Lumefantrine) Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Coartem (Artemether & Lumefantrine) Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Coartem (Artemether & Lumefantrine) Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Coartem (Artemether & Lumefantrine) Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Coartem (Artemether & Lumefantrine) Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Coartem (Artemether & Lumefantrine) Sales Value (2021-2032) & (US$ Million) Figure 37. South America Coartem (Artemether & Lumefantrine) Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Coartem (Artemether & Lumefantrine) Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Coartem (Artemether & Lumefantrine) Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Coartem (Artemether & Lumefantrine) Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Coartem (Artemether & Lumefantrine) Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Artemether
  • Lumefantrine
Applications
  • Retail Pharmacy
  • Online Pharmacy
  • Hospital Pharmacy
Companies covered
  • Novartis
  • Kunming Pharmaceutical
  • Kerui Nanhai Pharmaceutical
  • Guilin Pharmaceutical Co., Ltd
  • Guangxi Xiancaotang Pharmaceutical Co., LTD
  • Sanofi-Aventis
  • KPC Pharmaceuticals, Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Coartem (Artemether & Lumefantrine) Sales Value (2021-2032)
  4. 1.2.2 Global Coartem (Artemether & Lumefantrine) Sales Volume (2021-2032)
  5. 1.2.3 Global Coartem (Artemether & Lumefantrine) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Coartem (Artemether & Lumefantrine) Market Dynamics
  1. 2.1 Coartem (Artemether & Lumefantrine) Industry Trends
  2. 2.2 Coartem (Artemether & Lumefantrine) Industry Drivers
  3. 2.3 Coartem (Artemether & Lumefantrine) Industry Opportunities and Challenges
  4. 2.4 Coartem (Artemether & Lumefantrine) Industry Restraints
3 Coartem (Artemether & Lumefantrine) Market by Company
  1. 3.1 Global Coartem (Artemether & Lumefantrine) Company Revenue Ranking in 2025
  2. 3.2 Global Coartem (Artemether & Lumefantrine) Revenue by Company (2021-2026)
  3. 3.3 Global Coartem (Artemether & Lumefantrine) Sales Volume by Company (2021-2026)
  4. 3.4 Global Coartem (Artemether & Lumefantrine) Average Price by Company (2021-2026)
  5. 3.5 Global Coartem (Artemether & Lumefantrine) Company Ranking (2024-2026)
  6. 3.6 Global Coartem (Artemether & Lumefantrine) Company Manufacturing Base and Headquarters
  7. 3.7 Global Coartem (Artemether & Lumefantrine) Company Product Type and Application
  8. 3.8 Global Coartem (Artemether & Lumefantrine) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Coartem (Artemether & Lumefantrine) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Coartem (Artemether & Lumefantrine) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Coartem (Artemether & Lumefantrine) Market by Type
  1. 4.1 Coartem (Artemether & Lumefantrine) Type Introduction
  2. 4.1.1 Artemether
  3. 4.1.2 Lumefantrine
  4. 4.2 Global Coartem (Artemether & Lumefantrine) Sales Volume by Type
  5. 4.2.1 Global Coartem (Artemether & Lumefantrine) Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Coartem (Artemether & Lumefantrine) Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Coartem (Artemether & Lumefantrine) Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Coartem (Artemether & Lumefantrine) Sales Value by Type
  9. 4.3.1 Global Coartem (Artemether & Lumefantrine) Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Coartem (Artemether & Lumefantrine) Sales Value by Type (2021-2032)
  11. 4.3.3 Global Coartem (Artemether & Lumefantrine) Sales Value Share by Type (2021-2032)
5 Coartem (Artemether & Lumefantrine) Market by Application
  1. 5.1 Coartem (Artemether & Lumefantrine) Application Introduction
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Hospital Pharmacy
  5. 5.2 Global Coartem (Artemether & Lumefantrine) Sales Volume by Application
  6. 5.2.1 Global Coartem (Artemether & Lumefantrine) Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Coartem (Artemether & Lumefantrine) Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Coartem (Artemether & Lumefantrine) Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Coartem (Artemether & Lumefantrine) Sales Value by Application
  10. 5.3.1 Global Coartem (Artemether & Lumefantrine) Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Coartem (Artemether & Lumefantrine) Sales Value by Application (2021-2032)
  12. 5.3.3 Global Coartem (Artemether & Lumefantrine) Sales Value Share by Application (2021-2032)
6 Coartem (Artemether & Lumefantrine) Regional Sales and Value Analysis
  1. 6.1 Global Coartem (Artemether & Lumefantrine) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Coartem (Artemether & Lumefantrine) Sales by Region (2021-2032)
  3. 6.2.1 Global Coartem (Artemether & Lumefantrine) Sales by Region: 2021-2026
  4. 6.2.2 Global Coartem (Artemether & Lumefantrine) Sales by Region (2027-2032)
  5. 6.3 Global Coartem (Artemether & Lumefantrine) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Coartem (Artemether & Lumefantrine) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Coartem (Artemether & Lumefantrine) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Coartem (Artemether & Lumefantrine) Sales Value by Region (2027-2032)
  9. 6.5 Global Coartem (Artemether & Lumefantrine) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Coartem (Artemether & Lumefantrine) Sales Value (2021-2032)
  12. 6.6.2 North America Coartem (Artemether & Lumefantrine) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Coartem (Artemether & Lumefantrine) Sales Value (2021-2032)
  15. 6.7.2 Europe Coartem (Artemether & Lumefantrine) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Coartem (Artemether & Lumefantrine) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Coartem (Artemether & Lumefantrine) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Coartem (Artemether & Lumefantrine) Sales Value (2021-2032)
  21. 6.9.2 South America Coartem (Artemether & Lumefantrine) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Coartem (Artemether & Lumefantrine) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Coartem (Artemether & Lumefantrine) Sales Value Share by Country, 2025 VS 2032
7 Coartem (Artemether & Lumefantrine) Country-level Sales and Value Analysis
  1. 7.1 Global Coartem (Artemether & Lumefantrine) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Coartem (Artemether & Lumefantrine) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Coartem (Artemether & Lumefantrine) Sales by Country (2021-2032)
  4. 7.3.1 Global Coartem (Artemether & Lumefantrine) Sales by Country (2021-2026)
  5. 7.3.2 Global Coartem (Artemether & Lumefantrine) Sales by Country (2027-2032)
  6. 7.4 Global Coartem (Artemether & Lumefantrine) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Coartem (Artemether & Lumefantrine) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Coartem (Artemether & Lumefantrine) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Coartem (Artemether & Lumefantrine) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Coartem (Artemether & Lumefantrine) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Coartem (Artemether & Lumefantrine) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis
  2. 8.1.1 Novartis Company Information
  3. 8.1.2 Novartis Business Overview
  4. 8.1.3 Novartis Coartem (Artemether & Lumefantrine) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novartis Coartem (Artemether & Lumefantrine) Product Portfolio
  6. 8.1.5 Novartis Recent Developments
  7. 8.2 Kunming Pharmaceutical
  8. 8.2.1 Kunming Pharmaceutical Company Information
  9. 8.2.2 Kunming Pharmaceutical Business Overview
  10. 8.2.3 Kunming Pharmaceutical Coartem (Artemether & Lumefantrine) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Kunming Pharmaceutical Coartem (Artemether & Lumefantrine) Product Portfolio
  12. 8.2.5 Kunming Pharmaceutical Recent Developments
  13. 8.3 Kerui Nanhai Pharmaceutical
  14. 8.3.1 Kerui Nanhai Pharmaceutical Company Information
  15. 8.3.2 Kerui Nanhai Pharmaceutical Business Overview
  16. 8.3.3 Kerui Nanhai Pharmaceutical Coartem (Artemether & Lumefantrine) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Kerui Nanhai Pharmaceutical Coartem (Artemether & Lumefantrine) Product Portfolio
  18. 8.3.5 Kerui Nanhai Pharmaceutical Recent Developments
  19. 8.4 Guilin Pharmaceutical Co., Ltd
  20. 8.4.1 Guilin Pharmaceutical Co., Ltd Company Information
  21. 8.4.2 Guilin Pharmaceutical Co., Ltd Business Overview
  22. 8.4.3 Guilin Pharmaceutical Co., Ltd Coartem (Artemether & Lumefantrine) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Guilin Pharmaceutical Co., Ltd Coartem (Artemether & Lumefantrine) Product Portfolio
  24. 8.4.5 Guilin Pharmaceutical Co., Ltd Recent Developments
  25. 8.5 Guangxi Xiancaotang Pharmaceutical Co., LTD
  26. 8.5.1 Guangxi Xiancaotang Pharmaceutical Co., LTD Company Information
  27. 8.5.2 Guangxi Xiancaotang Pharmaceutical Co., LTD Business Overview
  28. 8.5.3 Guangxi Xiancaotang Pharmaceutical Co., LTD Coartem (Artemether & Lumefantrine) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Guangxi Xiancaotang Pharmaceutical Co., LTD Coartem (Artemether & Lumefantrine) Product Portfolio
  30. 8.5.5 Guangxi Xiancaotang Pharmaceutical Co., LTD Recent Developments
  31. 8.6 Sanofi-Aventis
  32. 8.6.1 Sanofi-Aventis Company Information
  33. 8.6.2 Sanofi-Aventis Business Overview
  34. 8.6.3 Sanofi-Aventis Coartem (Artemether & Lumefantrine) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Sanofi-Aventis Coartem (Artemether & Lumefantrine) Product Portfolio
  36. 8.6.5 Sanofi-Aventis Recent Developments
  37. 8.7 KPC Pharmaceuticals, Inc
  38. 8.7.1 KPC Pharmaceuticals, Inc Company Information
  39. 8.7.2 KPC Pharmaceuticals, Inc Business Overview
  40. 8.7.3 KPC Pharmaceuticals, Inc Coartem (Artemether & Lumefantrine) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 KPC Pharmaceuticals, Inc Coartem (Artemether & Lumefantrine) Product Portfolio
  42. 8.7.5 KPC Pharmaceuticals, Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Coartem (Artemether & Lumefantrine) Value Chain Analysis
  2. 9.1.1 Coartem (Artemether & Lumefantrine) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Coartem (Artemether & Lumefantrine) Sales Mode & Process
  6. 9.2 Coartem (Artemether & Lumefantrine) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Coartem (Artemether & Lumefantrine) Distributors
  9. 9.2.3 Coartem (Artemether & Lumefantrine) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst